Tag: Biotherapeutics

Arcutis Biotherapeutics Spotlights ZORYVE Surge, 2025 Revenue Beat and Key FDA Milestones at TD Cowen

Arcutis Biotherapeutics, a leading clinical-stage biopharmaceutical company, recently showcased its impressive performance and outlined upcoming regulatory and pipeline

Iovance Biotherapeutics, Inc. (IOVA): A Bull Case Theory

Iovance Biotherapeutics, Inc. (IOVA) is a company that is currently trading at $2.3500 as of January 13th. Despite